


January Therapeutics
Biotechnology Research • San Diego, California, United States • 1-10 Employees
Company overview
| Headquarters | 11575 Sorrento Valley Rd, San Diego, California 92121, US |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
Key Contact at January Therapeutics
Jason Kahana
Founder, Director, and President of R&D
About January Therapeutics
January Therapeutics is developing next generation targeted anti-cancer therapies. Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of known drugs, January is developing unique chemical matter to leverage well established anti-cancer mechanisms of action while adding new cancer targeting properties. Our goal is to create novel drugs with superior efficacy and reduced toxicity in hard-to-treat malignancies with initial application in advanced pancreatic, lung, and ovarian cancers.
January Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | $1,200,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
January Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
January Therapeutics Tech Stack
Discover the technologies and tools that power January Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Miscellaneous
Hosting
Programming languages
Web servers
Miscellaneous
Reviews
Programming languages
Reverse proxies
Hosting
Blogs
SSL/TLS certificate authorities
UI frameworks
Frequently asked questions
4.8
40,000 users



